Search

everythinglearnresearchcommunity

for

Search:↓

Combination of 0.25% finasteride and 3% minoxidil works better than just 3% minoxidil for increasing hair thickness in women.

Finasteride reduces prostate cancer risk by 30% without affecting Gleason scores.

Ziziphus jujuba Mills may have health benefits, but more research is needed to confirm its safety and effectiveness.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

Behavior therapy and medications, especially clomipramine, can help reduce hair pulling in people with trichotillomania.

Crescina® lotion helps reduce hair loss and increase hair growth in males with androgenetic alopecia.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

Finasteride gel effectively and safely reduces hair thickness in women with excessive hair growth.

Resveratrol improved hormone levels, menstrual cycles, hair loss, and ovarian function in PCOS patients.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

PDRN helps repair tissue and improve wound healing with a high safety profile.

Higher cholesterol levels increase aggressive prostate cancer risk.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

PRP injections help hair regrowth safely but may need more research.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

The document suggests a need for collaboration, better evidence, and a responsible framework to safely and effectively advance regenerative therapies to clinical use.

Gray hair is caused by reduced melanin production or transfer issues, linked to aging and possibly health conditions, with treatments focusing on color camouflage.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Melatonin applied to the scalp helps increase hair density in people with early hair loss.

Fat-derived stem cells show promise for skin repair and reducing aging signs but need more research for consistent results.

Kennedy's disease leads to muscle weakness without a cure, but exercise and managing symptoms may help patients live a normal lifespan.

Effective hair loss assessment requires a mix of precise measurement methods.

Monitoring new epilepsy drugs after they're sold is crucial to find rare and long-term side effects that initial tests might miss.

Androgens can both increase body hair and cause scalp hair loss.

A blood pressure drug, diltiazem, may also help treat influenza.

Myo-inositol and D-chiro-inositol improve hormonal and physical symptoms in teenage girls with PCOS.

A lotion with Centella asiatica extract reduced hair loss by 41% and increased hair strength without side effects.